SHH Equity Snapshot
688382 Weekly Equity Report
InventisBio Co., Limited
What the company does
InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China. The company's drug candidates for the oncology therapeutic area include BPI-D0316, which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; Taragarestrant, which is in Phase III clinical trial for the treatment of estrogen receptor positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer; and Gesorexel, which in Phase II clinical trial to treat various cancers, such as non-small cell lung cancer and colorectal cancer …
What the weekly tape is saying
688382 closed the latest completed week at 18.00 CNY. The 4-week return is -16.4% and the 12-week return is 1.8%. Trend Signal is inactive, Market Dynamics is -0.07. Setup signature: Risk-first tape with a 20/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 23.96 CNY
- Vs Trend Line
- -24.9%
- Fair Value
- 18.34 CNY
- Vs Fair Value
- -1.8%
- 52W High
- 49.68 CNY
- 52W Low
- 15.78 CNY
- Drawdown
- -63.8%
- Range Position
- 6.5%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 17
- 52W Active Breadth
- 32.7%
- Sector Scope
- CN Healthcare
- Sector Rank
- 65 of 486
- Sector Percentile
- 86.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CN Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -0.2%
- Avg 4W
- -7.7%
- Trend Breadth
- 15.0%
- Positive MD
- 24.0%
CN Biotechnology
- Tracked Peers
- 100
- 4W Rank
- 64 of 100
- Avg 1W
- -1.1%
- Avg 4W
- -13.2%
- Trend Breadth
- 13.0%
- Positive RS
- 10.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.07
- 4W MD Change
- 52.2%
- Relative Strength
- -40.38
- 4W RS Change
- -23.7%
- Expectation
- Negative
- Probability
- 40.21%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 66.2M
- 13W Average
- 80.7M
- 52W Average
- 71.8M
- Vs 13W
- 0.8x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.3%
- 52W Volatility
- 9.5%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 9.1% / -7.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- SHH
- Country
- CN
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- CNY
- Market Cap
- 10.4B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 18.00 CNY | 2.3% | 23.96 CNY | 18.34 CNY | -0.07 | -40.38 | 66.2M | Off |
| 5 Jun 2026 | 17.59 CNY | -9.8% | 24.19 CNY | 18.35 CNY | 0.04 | -42.34 | 66.9M | Off |
| 29 May 2026 | 19.50 CNY | -4.3% | 24.61 CNY | 18.37 CNY | 0.08 | -37.48 | 63.2M | Off |
| 22 May 2026 | 20.38 CNY | -5.3% | 24.86 CNY | 18.37 CNY | 0.00 | -35.73 | 68.0M | Off |
| 15 May 2026 | 21.53 CNY | -2.7% | 25.12 CNY | 18.38 CNY | -0.15 | -32.66 | 84.7M | Off |
| 8 May 2026 | 22.13 CNY | -5.0% | 25.34 CNY | 18.38 CNY | -0.28 | -31.70 | 51.5M | Off |
| 1 May 2026 | 23.30 CNY | 4.6% | 25.64 CNY | 18.37 CNY | -0.43 | -27.19 | 62.1M | Off |
| 24 Apr 2026 | 22.28 CNY | 1.0% | 25.91 CNY | 18.37 CNY | -0.42 | -29.98 | 91.2M | Off |
| 17 Apr 2026 | 22.07 CNY | 4.9% | 26.30 CNY | 18.35 CNY | -0.50 | -30.34 | 99.0M | Off |
| 10 Apr 2026 | 21.04 CNY | -7.7% | 26.78 CNY | 18.31 CNY | -0.69 | -32.60 | 77.9M | Off |
| 3 Apr 2026 | 22.80 CNY | 14.1% | 27.47 CNY | 18.29 CNY | -0.75 | -25.07 | 144.6M | Off |
| 27 Mar 2026 | 19.99 CNY | 13.1% | 27.99 CNY | 18.26 CNY | -0.89 | -34.84 | 96.8M | Off |
| 20 Mar 2026 | 17.68 CNY | -6.5% | 28.72 CNY | 18.24 CNY | -0.94 | -43.01 | 77.0M | Off |
| 13 Mar 2026 | 18.91 CNY | -11.6% | 29.49 CNY | 18.23 CNY | -0.85 | -41.18 | 83.7M | Off |